Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1288-94. doi: 10.1016/j.cgh.2013.11.039. Epub 2013 Dec 17.
BACKGROUND & AIMS: We investigated whether a diagnosis of colonic diverticular disease is associated with an increased risk for subsequent development of colorectal cancer (CRC) in a nationwide population-based retrospective study.
We identified 41,359 individuals diagnosed with colonic diverticular disease as inpatients from 2000 through 2009 from the Taiwan National Health Insurance Research Database (study cohort) and collected data for 165,436 randomly selected additional subjects, matched by sex, age, and baseline year (comparison cohort). Data were collected until individuals developed CRC or withdrew from the National Health Insurance system, or until December 31, 2010. Cumulative incidences and hazard ratios (HRs) of CRC development were determined. To assess for ascertainment bias, we conducted an analysis excluding the first 12 months of follow-up evaluation.
The risk of CRC was significantly higher in the study cohort than in the comparison cohort (HR adjusted for age, sex, and comorbidities, 4.54; 95% confidence interval, 4.19-4.91; P < .0001). In a sensitivity analysis, we excluded the first 12 months of follow-up evaluation after a diagnosis of colonic diverticular disease; subsequent incidence rates for CRC in the study and comparison cohorts were 15.13 and 15.74 per 10,000 person-years, respectively (adjusted HR, 0.96; 95% confidence interval, 0.83-1.11).
Colonic diverticular disease is not associated with an increased risk of subsequent CRC after the first year of diagnosis of colonic diverticular disease. An increased risk was observed in the first year, possibly owing to misclassification and screening effects.
本研究通过一项全国范围内基于人群的回顾性研究,旨在探讨结肠憩室疾病的诊断是否与结直肠癌(CRC)的发生风险增加相关。
我们从 2000 年至 2009 年的台湾全民健康保险研究数据库中确定了 41359 例因结肠憩室疾病住院的患者作为研究队列,并收集了 165436 名随机选择的性别、年龄和基线年份相匹配的额外患者的数据(对照队列)。数据收集至患者发生 CRC 或退出全民健康保险系统或截至 2010 年 12 月 31 日。确定 CRC 发生的累积发生率和风险比(HR)。为评估确定偏倚,我们进行了一项排除随访评估前 12 个月的分析。
研究队列的 CRC 风险明显高于对照队列(调整年龄、性别和合并症后的 HR,4.54;95%置信区间,4.19-4.91;P <.0001)。在一项敏感性分析中,我们排除了结肠憩室疾病诊断后的前 12 个月随访评估;研究和对照队列的 CRC 随后发生率分别为 15.13 和 15.74 每 10000 人年(调整后的 HR,0.96;95%置信区间,0.83-1.11)。
在诊断结肠憩室疾病后的第一年,结肠憩室疾病与随后发生 CRC 的风险增加无关。在第一年观察到风险增加,可能是由于分类错误和筛查效应。